392 related articles for article (PubMed ID: 21595033)
1. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
Park MR; Wang EH; Jin DC; Cha JH; Lee KH; Yang CW; Kang CS; Choi YJ
Proteomics; 2006 Feb; 6(3):1066-76. PubMed ID: 16372274
[TBL] [Abstract][Full Text] [Related]
3. Urinary exosomes and proteomics.
Moon PG; You S; Lee JE; Hwang D; Baek MC
Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
[TBL] [Abstract][Full Text] [Related]
4. Thin basement membrane nephropathy and IgA glomerulonephritis: can they be distinguished without renal biopsy?
Packham DK
Nephrology (Carlton); 2007 Oct; 12(5):481-6. PubMed ID: 17803472
[TBL] [Abstract][Full Text] [Related]
5. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria.
Shen P; He L; Jiang Y; Wang C; Chen M
Int J Clin Pract; 2007 May; 61(5):789-94. PubMed ID: 17362478
[TBL] [Abstract][Full Text] [Related]
6. Thin-basement-membrane nephropathy in adults with persistent hematuria.
Tiebosch AT; Frederik PM; van Breda Vriesman PJ; Mooy JM; van Rie H; van de Wiel TW; Wolters J; Zeppenfeldt E
N Engl J Med; 1989 Jan; 320(1):14-8. PubMed ID: 2909874
[TBL] [Abstract][Full Text] [Related]
7. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of urinary exosomes in cardiovascular and associated kidney diseases by two-dimensional electrophoresis and LC-MS/MS.
Zubiri I; Vivanco F; Alvarez-Llamas G
Methods Mol Biol; 2013; 1000():209-20. PubMed ID: 23585095
[TBL] [Abstract][Full Text] [Related]
9. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis.
Praga M; Martínez MA; Andrés A; Alegre R; Vara J; Morales E; Herrero JC; Novo O; Rodicio JL
Kidney Int; 1998 Sep; 54(3):915-20. PubMed ID: 9734616
[TBL] [Abstract][Full Text] [Related]
10. Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy.
Nakamura T; Sugaya T; Ebihara I; Koide H
Am J Nephrol; 2005; 25(5):447-50. PubMed ID: 16118482
[TBL] [Abstract][Full Text] [Related]
11. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
Wu J; Wang N; Wang J; Xie Y; Li Y; Liang T; Wang J; Yin Z; He K; Chen X
Rapid Commun Mass Spectrom; 2010 Jul; 24(14):1971-8. PubMed ID: 20552702
[TBL] [Abstract][Full Text] [Related]
12. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery.
Ngai HH; Sit WH; Jiang PP; Xu RJ; Wan JM; Thongboonkerd V
J Proteome Res; 2006 Nov; 5(11):3038-47. PubMed ID: 17081055
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN).
Auwardt R; Savige J; Wilson D
Clin Nephrol; 1999 Jul; 52(1):1-4. PubMed ID: 10442488
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy associated with thin basement membrane with or without inflammatory disease: getting a different prognosis?
Xu G; Tu W; Yu C; Xu C; Hu X; Wu W
Ren Fail; 2009; 31(6):452-6. PubMed ID: 19839821
[TBL] [Abstract][Full Text] [Related]
15. Thin basement membrane disease in patients with familial IgA nephropathy.
Frascá GM; Soverini L; Gharavi AG; Lifton RP; Canova C; Preda P; Vangelista A; Stefoni S
J Nephrol; 2004; 17(6):778-85. PubMed ID: 15593051
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of whole glomeruli in patients with IgA nephropathy using microsieving.
Kojima S; Koitabashi K; Iizuka N; Okamoto K; Arito M; Sato T; Kurokawa MS; Suematsu N; Shibagaki Y; Yasuda T; Kimura K; Kato T
Am J Nephrol; 2014; 39(1):36-45. PubMed ID: 24434790
[TBL] [Abstract][Full Text] [Related]
17. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
[TBL] [Abstract][Full Text] [Related]
18. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
19. Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity.
Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
Scand J Immunol; 2009 May; 69(5):457-64. PubMed ID: 19508377
[TBL] [Abstract][Full Text] [Related]
20. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
